CROI 2016: A Good Year for Metabolics (Video)
April 10, 2016
On behalf of IFARA, CARE community advisory board coordinator Jeff Taylor spoke with Jordan Lake, M.D., and Todd Brown, M.D., Ph.D., about research on preventing metabolic complications in people who are taking antiretroviral medications. The biggest news was a switch study for tenofovir alafenamide (TAF), a new version of tenofovir, which showed a 2% improvement in bone density for those taking the new form of the drug.
Another concern, chronic inflammation due to HIV, was found to improve in those who are 100% adherent to their medication regimen. While lipodystrophy is still an important issue for people living with HIV, research shows that it is possible to have a lot of body fat without metabolic problems. Overall, Dr. Lake called the period since CROI 2015 "a good year for metabolics."
Watch the video to learn more:
The video above has been posted on TheBodyPRO.com with permission from our partners at the International Foundation for Alternative Research in AIDS (IFARA). Visit IFARA's website or YouTube channel to watch more video interviews from the CROI 2016 conference, as well as earlier meetings.
Barbara Jungwirth is a freelance writer and translator based in New York.
Follow Barbara on Twitter: @reliabletran.
Copyright © 2016 Remedy Health Media, LLC. All rights reserved.
This article was provided by TheBodyPRO. It is a part of the publication The 23rd Conference on Retroviruses and Opportunistic Infections.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)
The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.